Clinical Trial Update: Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B [Phase 2]

View source ↗

Summary

This document reports a Phase II trial evaluating PEG-Tα1 in combination with Adefovir for HBeAg-positive chronic hepatitis B. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir (adefovir)
• PEG-Tα1 (pegylated thymosin alpha-1)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Hepatitis B, Chronic | Phase 2 | Status: COMPLETED